RTN4RL1

reticulon 4 receptor like 1

Basic information

Region (hg38): 17:1934677-2025334

Links

ENSG00000185924NCBI:146760OMIM:610461HGNC:21329Uniprot:Q86UN2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RTN4RL1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RTN4RL1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
2
clinvar
3
missense
13
clinvar
2
clinvar
15
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 13 1 4

Variants in RTN4RL1

This is a list of pathogenic ClinVar variants found in the RTN4RL1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-1936546-C-T not specified Uncertain significance (Feb 27, 2024)3157067
17-1936605-C-T not specified Uncertain significance (Jun 05, 2023)2551466
17-1936638-G-A not specified Uncertain significance (Feb 27, 2023)3157066
17-1936654-A-T not specified Uncertain significance (Oct 05, 2022)2316970
17-1936669-G-T not specified Uncertain significance (Jan 19, 2024)3157065
17-1936687-C-T not specified Uncertain significance (Jun 28, 2022)2207443
17-1936748-G-T not specified Uncertain significance (Sep 27, 2021)2252323
17-1936766-C-T Benign (Feb 20, 2018)790173
17-1936767-G-A not specified Uncertain significance (Jun 09, 2022)3157064
17-1936853-C-A not specified Uncertain significance (Dec 21, 2022)2376213
17-1936899-G-A Benign (Nov 20, 2017)780389
17-1936918-G-A not specified Uncertain significance (Mar 30, 2024)2280286
17-1936932-C-T not specified Uncertain significance (Mar 16, 2024)3315726
17-1936960-G-A not specified Uncertain significance (Jan 17, 2024)3157069
17-1936988-G-A Likely benign (May 01, 2022)2647213
17-1937009-C-A not specified Uncertain significance (Apr 07, 2022)2229373
17-1937034-G-A not specified Uncertain significance (Jun 30, 2022)3157068
17-1937168-G-A Benign (Feb 20, 2018)709926
17-1937383-C-T Benign (Jan 05, 2018)774926

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RTN4RL1protein_codingprotein_codingENST00000331238 290669
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9600.0397124586011245870.00000401
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.472122810.7530.00001902813
Missense in Polyphen59111.980.526861212
Synonymous-0.5091481401.050.0000106940
Loss of Function2.94010.10.004.29e-7119

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004640.0000464
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Cell surface receptor. Plays a functionally redundant role in postnatal brain development and in regulating axon regeneration in the adult central nervous system. Contributes to normal axon migration across the brain midline and normal formation of the corpus callosum. Protects motoneurons against apoptosis; protection against apoptosis is probably mediated by MAG. Plays a role in inhibiting neurite outgrowth and axon regeneration via its binding to neuronal chondroitin sulfate proteoglycans. Binds heparin (By similarity). Like other family members, plays a role in restricting the number dendritic spines and the number of synapses that are formed during brain development (PubMed:22325200). Signaling mediates activation of Rho and downstream reorganization of the actin cytoskeleton (PubMed:22325200). {ECO:0000250|UniProtKB:Q8K0S5, ECO:0000269|PubMed:22325200}.;
Pathway
Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins (Consensus)

Recessive Scores

pRec
0.116

Intolerance Scores

loftool
0.0741
rvis_EVS
0.4
rvis_percentile_EVS
76.36

Haploinsufficiency Scores

pHI
0.544
hipred
N
hipred_score
0.498
ghis
0.443

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.214

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rtn4rl1
Phenotype
liver/biliary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype;

Gene ontology

Biological process
negative regulation of neuron projection development;corpus callosum development;axon regeneration;negative regulation of axon regeneration
Cellular component
extracellular region;extracellular space;plasma membrane;external side of plasma membrane;cell surface;extracellular matrix;cell projection;perikaryon;membrane raft;anchored component of plasma membrane;extracellular exosome
Molecular function
protein binding;heparin binding;chondroitin sulfate binding;signaling receptor activity